Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1α

被引:251
作者
Elson, DA
Thurston, G
Huang, LE
Ginzinger, DG
McDonald, DM
Johnson, RS
Arbeit, JM [1 ]
机构
[1] Univ Calif San Francisco, Ctr Comprehens Canc, Canc Genet Program, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Ctr Comprehens Canc, Genome Anal Core Facil, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA
[5] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA
[6] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[7] NCI, Human Carcinogenesis Lab, NIH, Bethesda, MD 20892 USA
[8] Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA
关键词
hypoxia; HIF-1; alpha; angiogenesis; skin; epidermis; keratin;
D O I
10.1101/gad.914801
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Hypoxia-inducible factor-1 alpha (HIF-1 alpha) transactivates genes required for energy metabolism and tissue perfusion and is necessary for embryonic development and tumor explant growth. MF-la is overexpressed during carcinogenesis, myocardial infarction, and wound healing; however, the biological consequences of HIF-1 alpha overexpression are unknown. Here, transgenic mice expressing constitutively active HIF-1 alpha in epidermis displayed a 66% increase in dermal capillaries, a 13-fold elevation of total vascular endothelial growth factor (VEGF) expression, and a six- to ninefold induction of each VEGF isoform. Despite marked induction of hypervascularity, HIF-1 alpha did not induce edema, inflammation, or vascular leakage, phenotypes developing in transgenic mice overexpressing VEGF cDNA in skin. Remarkably, blood vessel leakage resistance induced by HIF-1 alpha overexpression was not caused by up-regulation of angiopoietin-1 or angiopoietin-2. Hypervascularity induced by HIF-1 alpha could improve therapy of tissue ischemia.
引用
收藏
页码:2520 / 2532
页数:13
相关论文
共 60 条
  • [1] Arbeit JM, 1996, CANCER SURV, V26, P7
  • [2] PROGRESSIVE SQUAMOUS EPITHELIAL NEOPLASIA IN K14-HUMAN PAPILLOMAVIRUS TYPE-16 TRANSGENIC MICE
    ARBEIT, JM
    MUNGER, K
    HOWLEY, PM
    HANAHAN, D
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (07) : 4358 - 4368
  • [3] Arbeit JM, 1996, ONCOGENE, V13, P1847
  • [4] UP-REGULATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR EXPRESSION INDUCED BY MYOCARDIAL-ISCHEMIA - IMPLICATIONS FOR CORONARY ANGIOGENESIS
    BANAI, S
    SHWEIKI, D
    PINSON, A
    CHANDRA, M
    LAZAROVICI, G
    KESHET, E
    [J]. CARDIOVASCULAR RESEARCH, 1994, 28 (08) : 1176 - 1179
  • [5] Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188
    Carmeliet, P
    Ng, YS
    Nuyens, D
    Theilmeier, G
    Brusselmans, K
    Cornelissen, I
    Ehler, E
    Kakkar, VV
    Stalmans, I
    Mattot, V
    Perriard, JC
    Dewerchin, M
    Flameng, W
    Nagy, A
    Lupu, F
    Moons, L
    Collen, D
    D'Amore, PA
    Shima, DT
    [J]. NATURE MEDICINE, 1999, 5 (05) : 495 - 502
  • [6] Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
    Carmeliet, P
    Moons, L
    Luttun, A
    Vincenti, V
    Compernolle, V
    De Mol, M
    Wu, Y
    Bon, F
    Devy, L
    Beck, H
    Scholz, D
    Acker, T
    DiPalma, T
    Dewerchin, M
    Noel, A
    Stalmans, I
    Barra, A
    Blacher, S
    Vandendriessche, T
    Ponten, A
    Eriksson, U
    Plate, KH
    Foidart, JM
    Schaper, W
    Charnock-Jones, DS
    Hicklin, DJ
    Herbert, JM
    Collen, D
    Persico, MG
    [J]. NATURE MEDICINE, 2001, 7 (05) : 575 - 583
  • [7] Angiogenesis in cancer and other diseases
    Carmeliet, P
    Jain, RK
    [J]. NATURE, 2000, 407 (6801) : 249 - 257
  • [8] Vascular endothelial growth factor enhances atherosclerotic plaque progression
    Celletti, FL
    Waugh, JM
    Amabile, PG
    Brendolan, A
    Hilfiker, PR
    Dake, MD
    [J]. NATURE MEDICINE, 2001, 7 (04) : 425 - 429
  • [9] Chalkley HW, 1943, J NATL CANCER I, V4, P47
  • [10] Mosaic blood vessels in tumors: Frequency of cancer cells in contact with flowing blood
    Chang, YS
    di Tomaso, E
    McDonald, DM
    Jones, R
    Jain, RK
    Munn, LL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (26) : 14608 - 14613